Status:
ACTIVE_NOT_RECRUITING
Automation of the In Vitro Fertilization Laboratory
Lead Sponsor:
Conceivable Life Sciences
Collaborating Sponsors:
Hope Fertility Center
Reina Madre
Conditions:
Infertility
ART
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Enrolled patients will undergo an Assisted Reproductive technology (ART) treatment using intracytoplasmic sperm injection (ICSI, the direct injection of a single sperm cell into an oocyte) as the meth...
Eligibility Criteria
Inclusion
- Informed consent signed by the patients before treatment.
- Medical indication to perform assisted reproductive technology.
- Body mass index between 20 and 29 kg/m2 (female participants only).
- For women with indication of utilizing autologous eggs:
- Anti-Müllerian Hormone (AMH) value of at least 1.5 ng/mL.
- 18 - 39 years of age.
- For women utilizing donor eggs (egg donor age 18-28 years):
- 18 - 45 years of age.
Exclusion
- Patients diagnosed with recurrent pregnancy loss.
- Inaccessible ovaries for puncture.
- History of total or partial fertilization failure in a previous fertility treatment.
- History of repeated implantation failure defined as three previous unsuccessful embryo transfers.
- Uterine factors (e.g. fibroids, uterine surgeries, Müllerian malformations) at the discretion of the medical team and based on its impact on success and/or risk to the patient or the pregnancy may compromise treatment prognosis).
- Untreated hydrosalpinx
- Severe endometriosis III, IV, presence of endometriomas and/or history of endometrioma resection.
- Polycystic ovarian syndrome.
- Patients with any of the following severe male factor infertility:
- Sperm concentrations less than 5 million per mL
- Progressive motility less than 5%
- Others (e.g, globozoospermia and seminal infections) at the discretion of the medical team and based on its impact on success.
- Surgically retrieved sperm (TESE, MESA, PESA)
- Pre-existing conditions compromising reproductive (e.g., thrombophilia, chronic degenerative and autoimmune diseases, uncontrolled hormonal disorders).
- Any other case of abnormalities that could compromise success rates according to the criteria of clinical personnel in charge.
- Inability to adhere to the medical protocols and/or schedules for personal reasons.
- Intercurrent medical disorder
Key Trial Info
Start Date :
December 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06581068
Start Date
December 3 2024
End Date
December 1 2026
Last Update
November 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New Hope Fertility Centre, Mexico City
Mexico City, Mexico City, Mexico, 11000
2
Reina Madre
Mexico City, Mexico